The IRDiRC Companies Constituent Committee (CCC) is pleased to welcome PacBio as its newest member, represented by Nina Gonzaludo, Global Lead Human Genomics, based in the USA.
PacBio is a global leader in long-read sequencing technologies, enabling more comprehensive and accurate genomic insights. These advances play a critical role in accelerating progress in rare disease research and improving diagnostic capabilities.
With PacBio’s participation, the CCC further strengthens its mission to foster collaboration between industry partners and the rare disease community, helping translate scientific discoveries into meaningful solutions that benefit patients worldwide.
We warmly welcome PacBio, and we look forward to advancing rare disease research together.
Learn more about PacBio: www.pacb.com
More about the CCC: https://irdirc.org/companies-constituent-committee-ccc/